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In the 1980s it became apparent that a closer 
liaison with the National Institutes of Health (NIH) 
and one of its major branches, the National Heart, 
Lung, and Blood Institute (NHLBI), would be of 
great benefit to the members of The Society for 
Vascular Surgery. In addition, if an interchange of 
ideas could evolve, it could be of importance tothose 
interested in research devoted to vascular problems. It
was during this time that I was serving on the 
Cardiology Advisory Committee of the NHLBI. This 
committee was charged to deal with matters related to 
both the heart and the peripheral vascular system. 
There was a feeling on the committee that he area of 
peripheral vascular disease had not been properly 
addressed by the Institute over the years. We were 
fortunate to have Dr. Robert W. Barnes precede me 
on the committee and help set the stage for a more 
comprehensive collaboration. During my tenure, dis- 
cussions were begun with Dr. John Watson, the Chief 
of the Devices and Technology Branch of NHLBI, 
about he possibility of putting together a workshop 
on vascular disease to be held in Bethesda, Md. The 
idea behind such an effort was to try to stimulate 
interest in the scientific community about this area 
that had been underserved in the past. This workshop 
was supported by NHLBI. It was also the intent of the 
program to attract the best scientific minds available in 
the research community to provide insight into the 
status of vascular esearch in this country. This new 
information could then be taken back to the Cardi- 
ology Advisory Committee and the NIH to inform 
the leadership about he areas that needed more work. 
This in turn could lead to the development of and 
dissemination f initiatives to the research community 
for possible funding. 
The topics for this first workshop were broad in 
scope but provided a framework for the subsequent 
programs that evolved from this experience. Some of 
the topics covered in the first meeting included the 
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scope of the problem of vascular disease, the nature of 
atherosclerotic plaque, venous thromboembolism, 
vasospastic disorders, the available diagnostic meth- 
ods, the status of cellular and molecular biology, 
blood flow, vascular healing, vascular grafts, and the 
pathophysiology of acute venous disorders. The pro- 
ceedings of this conference r sulted in a book entitled 
Vascular Diseases: Current Research and Clinical Ap- 
plications, which appeared in 1987.1 
Because of the success of this initial venture, 
negotiations were held with Dr. Claude Lenfant, the 
director of NHLBI, about the feasibility of joint 
sponsorship of future meetings of this type. The joint 
council approved this proposal, and we began to move 
forward. The collaborative effort was agreed to, and 
the first announcement about his effort went out to 
the membership in January 1988. Although it was not 
certain at that time whether this program would 
become an annual event, subsequent history and the 
success of the endeavor left little doubt about its 
future. This success led to the establishment of what 
became known as the Research Initiatives Meetings 
(appendix). These meetings have been held annually 
for the past 10 years. The meeting format and topics 
have been under the guidance of members of The 
Society for Vascular Surgery and have been approved 
by them. The efforts in this regard have been led by 
me, Dr. Frank LoGerfo, Dr. Patrick Claggett, and Dr. 
Alexander Clowes. The meetings have been held in 
Bethesda, Md., in February or March of each year. 
The first jointly sponsored meeting was held 
February 19 and 20, 1988. The opening lecture was 
given by Dr. John Watson from NHLBI, who re- 
viewed the perspectives on research in vascular dis- 
eases from the standpoint ofthe Institute. This lecture 
was followed by papers on hemodynamics and the 
arterial wall, diagnostic approaches, new strategies in 
intervention, adaptive responses of arteries, the arte- 
rial wall response to injury, mechanisms of graft 
failure, aneurysmal disease, atherosclerosis, lipids, and 
the arterial wall. At the time of this meeting, the topics 
were again of broad and general interest o the 
medical community. As will be noted, future confer- 
ences became much more focused. 
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After this initial conference, Dr. Frank LoGerfo 
took over the responsibility for the subject, content, 
and design of the conferences. The second Research 
Initiatives Meeting was devoted to a consideration of
NIH-funded research in vascular surgery mad a wide 
variety of research topics. These topics included 
mechanisms of smooth muscle cell proliferation, the 
role of smooth muscle fimction in intimal hyperplasia, 
and the role of the macrophage in intimal hyperplasia. 
The regulation of growth factors by the endothelium 
and the contribution of mechanical stress to this entire 
process was reviewed. The topics then focused on the 
overall problem ofintimal hyperplasia, its prevalence, 
and its impact from a clinical standpoint. The impor- 
tance ofintimal hyperplasia nvein grafts was covered, 
as was the progress being made in inhibiting this 
process experimentally. 
The third conference was held in February 1990 
and was devoted to the problems of "Thrombosis, 
Thrombolysis, and Antithrombotic agents." In addi- 
tion, the current knowledge relating to hypercoagu- 
able states was reviewed. Representatives from 
NHLBI presented information on the status of the 
Academic Awards in Systemic and Pulmonary Vascu- 
lar Disease. The current initiatives in the Cardiac 
Diseases Branch were also presented. This was the first 
conference in which papers on endothelial function 
and gene therapy were presented. The problems 
related to gene transfer were reviewed. Finally, the 
issue of blood and materials interaction was covered. 
This is an area of great importance to all vascular 
surgeons. 
In 1991 the entire conference was devoted to 
problems related to "Prosthetic Grafts in the Arterial 
System." Because prosthetic grafts have been used in 
vascular surgery nearly from its inception as a spe- 
cialty, they is a topic of great importance. The role Of 
the surface covering of the grafts and the prospects for 
endothelial seeding were reviewed. A major problem 
with prosthetic grafts relates to the compliance mis- 
match present and the intimal hyperplasia that devel- 
ops at the anastomoses. Although these problems 
remain largely unsolved, the current state of our 
knowledge in these areas was reviewed. Because 
prosthetic graft infection is always a challenge in 
management, an entire session was devoted to the 
problem. 
The 1992 conference was devoted entirely to the 
rapidly expanding field of "Molecular Biology and 
Vascular Surgery." Although molecular biology is an 
area of great interest to basic scientists, it was also clear 
from this conference that vascular surgeons were also 
beginning to play a role in this challenging field. The 
fundamental concepts necessary to understand the 
use of these new tools were reviewed. There was a 
major session devoted to genetic vascular disease. The 
one area of immediate interest o vascular surgeons 
was the abdominal aortic aneurysm and its relation- 
ship to genetic factors. A great deal of time was de- 
voted to gene expression i  endothelial nd smooth 
muscle cells. The final session was devoted to the po- 
tential role for gene therapy and genetic engineering. 
In 1993 the conference was designed to review the 
progress being made in "Ischemia/Reperfusion." 
This issue is of great interest to vascular surgeons, who 
have to deal with the problem of acute ischemia in 
many different vascular beds. The clinical relevance of 
the problems and the contributing factors were re- 
viewed in a single session. Another session was de- 
voted to the problems related to skeletal muscle and 
the splanchnic bed. The review not only touched on 
the clinical aspects but also the basic pathophysiology 
involved in the generation of the clinical problems. 
In 1994 the symposium highlighted the emerging 
area of "Transluminally Placed Endovascular Pros- 
theses." This was a very timely topic that, with time, 
has been shown to be of great interest and impor- 
tance. NIH representatives brought he participants 
up to date on the activities of the devices and 
technology branch of NHLBI. In addition, the newly 
established programs in vascular biology, medicine, 
and surgery at NHLBI were reviewed. Finally, the 
new initiatives from the Division of Heart and Vascu- 
lar Diseases were reviewed. The topics reviewed 
included some basic considerations ofatherosclerosis, 
with particular emphasis on the advantages and short- 
comings of animal models. The role of thrombosis n 
the atherosclerotic models and humans was also 
reviewed in a session devoted to this problem. The 
mechanisms of healing of prosthetic grafts was also 
reviewed, followed by a session devoted to intimal 
hyperplasia. 
A minisymposium onNIH funding opportunities 
for vascular surgeons was held. This included consid- 
eration of the importance of research training and its 
availability. The Harvard-Longwood Training Pro- 
gram in Vascular Surgical Research was presented by 
Dr. Frank LoGerfo. Finally, a review of how, why, and 
what grants get fimded was presented by Dr. Paul 
Parakkal from the Scientific Review Branch of NIH. 
A session was devoted to aortic aneurysms, with 
particular emphasis on experimental models and how 
they might apply to human beings. This session was 
followed by a symposium on the current status of 
transluminally placed endovascular p ostheses. This 
was one of the first scientific sessions devoted entirely 
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to this new and important field. It was clear f om this 
session what some of the problems were likely to be 
and how they might be approached. The early clinical 
experience and problems being encountered were 
also reviewed. 
In 1995 the conference was tal:en over by Dr. 
Alexander W. Clowes, who devoted the conference to
"Atherosclerosis and Restenosis: The Failure of Con- 
ventional Wisdom." Problems related to the use of 
animal models were reviewed. The limitations of these 
models were covered in great detail. Another session 
was devoted to available and new techniques for 
studying vascular disease in human beings. Because 
thrombosis a prominent feature found in athero- 
sclerosis, the question as to why some lesions lead to 
thromboembolic symptoms was addressed in a ses- 
sion. The issues related to plaque progression and the 
problems associated with abnormalities of vasomotor 
function were addressed in a single session. Finally, 
the mechanisms ofrestenosis a they relate to vascular 
reconstructions was reviewed in some depth. 
The tenth anniversary ofthis conference was held 
March 7 and 8, 1996. Dr. Alexander W. Clowes 
organized a conference devoted to the issue of"Vas- 
cular Gene Transfer: Models of Disease and Therapy," 
an in-depth examination ofone of the more exciting 
areas in biologic research. This program provided 
A-to-Z coverage of the subject, which should be of 
great interest to those who have interests in this field. 
Another worthwhile ffort on the part of the 
Society was to have the proceedings of these confer- 
ences published in the Journal of Vascular Surgery. 
This policy was important to those who were unable 
to attend these important meetings. 
After 50 years for The Society for Vascular Surgery 
and the 10th Anniversary of the Research Initiatives 
Meetings, one must fairly ask to what extent his 
collaborative effort has been a success. It is my view 
that it has succeeded in many different ways. First, and 
perhaps most importantly, it has provided aforum for 
an interchange of ideas and in-depth discussion of 
important problems. In addition, because it is held 
annually, most opics that are discussed are timely and 
up-to-date. Both the NIH and the scientific ommu- 
nity have benefited from this type of exposure. Has it 
in any way increased the flow of funds to our col- 
leagues? I do not know, but I think that hat issue is in 
many respects irrelevant to the goals of the confer- 
ence. As one will note from the programs over the 
years, the topics reviewed at the meetings have been of 
increasing complexity. This is in a sense a mirror of 
what is happening in real life. In addition, these 
conferences do provide a forum for "science," which 
is often put aside these days because of our concerns 
over health care delivery and cost containment. Al- 
though there is no argument over concerns related to 
health care delivery, the solutions to many of our 
problems in the future will come from the basic 
science community. It is my view that he leadership of 
The Society for Vascular Surgery should be com- 
mended for urging this kind of collaborative effort. 
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APPENDIX. PROGRAMS OF THE 
RESEARCH INITIATIVES MEETINGS 
1988 
Opening Lecture. Research in Vascular Disease: Per- 
spectives of NHLBI. John T. Watson, PhD 
SESSION I. Moderator: John T. Watson, PhD 
Hemodynamics and the Arterial Wall. Frank W. 
LoGerfo, MD, Don P. Giddens, PhD 
Diagnostic Approaches. D. E. Strandness, Jr., MD, 
Henry D. Berkowitz, MD 
New Strategies In Intervention. Rodney A. White, 
MD, Thomas Fogarty, MD 
Panel Discussion. Moderator: John T. Watson, PhD. 
Panelists: FrankW. LoGerfo, MD, Don P. Giddens, 
PhD, D. E. Strandness, Jr., MD, Henry D. B erkow- 
itz, MD, Rodney A. White, MD, Thomas Fogarty, 
MD, Alan S. Berson, PhD 
SESSION II. Moderator: James C. Stanley, MD 
Adaptive Responses of Arteries. Christopher K. 
Zarins, MD, William M. Abbott, MD 
Arterial Wall Response to Injury and Healing. Sey- 
mour Glagov, MD, Alexander W. Clowes, MD 
Mechanisms of Graft Failure. Harry L. Bush, Jr., MD, 
Dennis F. Bandyk, MD 
Panel Discussion. Moderator: James C. Stanley, MD. 
Panelists: Christopher K. Zarins, MD, William M. 
Abbott, MD, Seymour Glagov, MD, Alexander W. 
Clowes, MD, Harry L. Bush, Jr., MD, Dennis F. 
Bandyk, MD, Paul Didisheim, MD 
SESSION III. Moderator: John M. Porter, MD 
Aneurysmal Disease. M. David Tilson, MD, Philip 
Dobrin, MD, PhD 
Thrombosis and Thrombolysis. Patrick G. Claggctt, 
MD, John M. Porter, MD 
Atherosclerosis, Lipids, and the Arterial Wall. William 
Lands, PhD, Joseph H. Rapp, MD 
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Panel Discussion. Moderator: John M. Porter, MD. 
Panelists: M. David Tilson, MD, Phillip Dobrin, 
MD, Patrick G. Claggett, MD, William Lands, 
PhD, Gardiner C. McMillen, MD, Joseph H. Rapp, 
MD 
1989 
Introductory Comments. Frank W. LoGerfo, MD 
NIH Funded Research in Vascular Surgery. Paul 
Didishem, MD 
SESSION I. Moderator: Russell Ross, MD 
Mechanisms of Smooth Muscle Proliferation--The 
Rule of Cytokines and Growth Factors. Russell 
Ross, MD 
Smooth Muscle Cell Function in Intimal Hyperplasia. 
Peter Libby, MD 
The Role of Macrophage in Intimal Hyperplasia. 
Howard Greisler, MD 
Regulation of Growth Factor by Endothelium. Paul 
DiCorleto, MD 
Mechanical Stress and Cell Growth. Bauer Sumpio, 
MD 
Panel Discussion. Moderator: Russell Ross, MD. 
Panelists: Paul Didisheim, MD Peter Libby, MD, 
Howard Greisler, MD, Paul D iCorleto, MD, Baner 
Sumpio, MD 
SESSION II. Moderator: Christopher K. Zarins, MD 
What is Intimal Hyperplasia? Seymour Glagov, MD 
Morphology of Intimal Hyperplasia. Christian C. 
Haudenschild, MD 
Endarterectomy-Induced Intimal Hyperplasia. Harry 
L. Bush, Jr., MD 
Panel Discussion. Moderator: Christopher K. Zarins, 
MD. Panelists: Seymour Glagov, MD, Christian C. 
Haudenschild, MD, Harry L. Bush, Jr., MD 
SESSION III. Moderator: Jerry Goldstone, MD 
Intimal Hyperplasia nd Restenosis Following Ca- 
rotid Endarterectomy. G. Patrick Claggett, MD 
Infimal Hyperplasia and Restenosis Following Coro- 
nary Angioptasty. Wade McBride, MD 
Biomechanics ofAnastomotic Hyperplasia. Frank W. 
LoGerfo, MD 
Panel Discussion. Moderator: Jerry Goldstone, MD. 
Panelists: G. Patrick Claggett, MD, Wade McBride, 
MD, Frank W. LoGerfo, MD 
SESSION IV. Moderator: Frank W. LoGerfo, MD 
Vein Grafts: Clinical Aspects of Intimal Hyperplasia. 
Jonathan B. Towne, MD 
Vein Grafts: Pathobiology of Intimal Hyperplasia. 
Jerome I. Brody, MD 
Vein Grafts: Implantation I jury. Gayle D. Adcock, 
PhD 
Panel Discussion. Moderator: Frank W. LoGerfo, 
MD. Panelists: Jonathan B. Towne, MD, Jerome I. 
Brody, MD, Gayle D. Adcock, PhD 
SESSION V. Moderator: Jack L. Cronenwett, MD 
Heparin Inhibition oflntimal Hyperplasia. Alexander 
W. Clowes, MD 
Inhibition of Adhesive Receptors. Jack Hawiger, MD, 
PhD 
Intimal Hyperplasia: In Vivo Mechanisms (Im- 
munologic, Mitogenic, and Eicosanoid), Lipo- 
protein Peroxidation, and Treatment with 
OMEGA-3 Fatty Acids. D. Craig Miller, MD 
Panel Discussion. Moderator: Jack L. Cronenwett, 
MD. Panelists: Alexander W. Clowes, MD, Jack 
Hawiger, MD, PhD, D. Craig Miller, MD 
1990 
Welcome. Frank W.LoGerfo, MD 
NHLBI PROGRAMS AND INITIATIVES. 
Moderator: Paul Didisheim, MD 
NHLBI Academic Award in Systemic and Pulmonary 
Vascular Disease. John C. Hoak, MD 
Initiatives in Cardiac Diseases Branch. Constance 
Weinstein, MD 
THROMBOLYSIS. Moderator: John M. Porter, 
MD 
New Developments in Thrombolytic Therapy. Desire 
Collen, MD 
Thrombin After Clot Formation. John W. Fenton, II, 
MD 
Thrombolytic Agents in Venous Thrombosis. Alex- 
ander G. G. Turpie, MD 
Intraoperative Thrombolysis. Anthony J. Comerota, 
MD, FACS 
Thrombolytic Therapy in Perspective. John M. Por- 
ter, MD 
ANTITHROMBOTIC AGENTS. Moderator: G. 
Patrick Clagett, MD 
Hirudin: A Thrombin Inhibitor. James Chesebro, 
MD 
Thromboxane Inhibition. Jack L. Cronenwett, MD 
Prostaglandins as Antithrombotic Agents. V. Paul 
Adonizio, MD 
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HYPERCOAGUABLE STATES. Moderator: Chris- 
topher K. Zarins, MD 
Clinical Aspects of Hypercoagulable States. Jonathan 
B. Towne, MD 
Hypercoagulability in Arterial Thrombosis: New Per- 
spectives from Epidemiologic Studies. Kenneth K. 
Wu, MD 
Antithrombin III: Clinical Trials in Hip and Knee 
Replacement. Charles W. Francis, MD 
ENDOTHELIAL FUNCTIONS AND GENE 
TRANSFER. Moderator: James C. Stanley, MD 
Endothelial Cell Fibrinolytic Assembly. Ralph L. 
Nachman, MD 
Gene Transfer into Endothelial Cells. W. French 
Anderson, MD 
Endothelial Cell Gene Transfer: Experimental Reali- 
ties, Therapeutic Possibilities. Louis K. Birinyi, MD 
BLOOD--MATERIALS INTERACTION. 
Moderator: Frank W. LoGerfo, MD 
Blood Contact Activation During Cardiopnlmonary 
Bypass. L. Henry Edmunds, Jr., MD 
Platelet Materials Interaction. Laurence Harker, MD 
The Role of Plasma Protein in Platelet Activation by 
Artificial Surfaces. Jack Lindon, PhD 
1991 
Welcome. Frank W. LoGerfo, MD 
NHLBI Programs and Initiatives. Paul Didisheim, 
MD, John L. Fakunding, PhD 
SESSION I. Moderator: Allan D. Callow, MD, PhD 
Endothelial Biology Applied to Materials and De- 
vices. Una S. Ryan, PhD 
Quantitative Studies of Endothelial Adhesion Using 
Confocal Image Analysis. Peter Davies, PhD 
Endothefial Seeding. Malcolm B. Herring, MD 
Microvessel Derived Endothelial Cells Isolation, Ad- 
herence, and Monolayer Formation for Vascular 
Grafts. Bruce E. Jarrell, MD 
Graft Endothelialization: The Role of Angiogenic 
Mechanisms. Alexander W. Clowes, MD 
Genetic Manipulation of Seeded Endothelial Cells in 
Vascular Prostheses. James C. Stanley, MD 
SESSION II. Moderator: Gregorio A. Sicard, MD 
Relationship Between Anastomotic Hemodynamics 
and Intimal Thickening. Christopher K. Zarins, 
MD 
The Blood/Materials Interaction and Downstream 
Effects in Prosthetic Conduits. Frank W. LoGerfo, 
MD 
PDGF Production Following Prosthetic Graft Im- 
plantation. Linda M. Graham, MD 
Modulation of Cell Growth by Mechanical Stretch. 
Bauer E. Sumpio, MD, PhD 
SESSION III. Moderator: Anthony D. Whittemore, 
MD 
Elastic Protein-Based Polymers as Cell Attachment 
Matrices. Dan W. Urry, PhD 
Absorbable Materials and Macrophage Interactions. 
Howard P. Greisler, MD 
Human Blood Protein and Cellular Interactions in 
the Healing Responses of Vascular Protheses. 
James M. Anderson, MD, PhD 
NIH Grant Application Process and Guidelines: Ses- 
sion for New Grant Applicants. James S. T. Yao, 
MD, PhD, Paul Parakkal, PhD 
SESSION IV. Moderator: Richard F. Kempczinski, 
MD 
A Critical Analysis of Clinical Prosthetic Graft Infec- 
tions. Vincent G. Pons, MD 
Utilizing Vascular Protheses for Drug Delivery. Ralph 
S. Greco, MD 
Pathogenesis of Graft Infections. Richard L. Sim- 
mons, MD 
Prosthetic Infections Due to Bacterial Laden 
Biofilms: Experimental nd Clinical Observations. 
Dennis F. Bandyk, MD 
SESSION V. Moderator: James S. T. Yao, MD 
SMC Growth Inhibition: Experimental Data, Ratio- 
nale and Future Directions. Fredrick J. Schoen, 
MD, PhD 
Antithrombotic Agents: Experimental Data, Ratio- 
nale and Future Directions. Edwin W. Salzman, 
MD 
Clinical Trials: Current Status and Recommenda- 
tions. G. Patrick Clagett, MD 
1992 
Opening Remarks. G. Patrick Clagett, MD, Claude 
Lenfant, MD 
Vascular Diseases: An Approach for the 1990s. David 
M. Robinson, PhD 
Training and Career Opportunities Supported by the 
National Heart, Lung, and Blood Institute. John 
Fakunding, PhD 
SESSION I. Molecular Biology: The Science and the 
Jargon. Moderator: G. Patrick Clagett, MD 
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Fundamental Concepts in the Preparation and Analy- 
sis of DNA and RNA. Bauer E. Sumpio, MD 
Use of the Linked Reverse Transcription/Polymerase 
Chain Reactin for mRNA Phenotyping of Vascular 
Wall Cells. John B. Sharefldn, MD 
Cloning and Expression of Human Erythropoietin, a 
Paradigm. Carl W. Dieffenbach, PhD 
Molecular Biology--Vascular Health and Disease. 
Una S. Ryan, PhD 
Panel Discussion: Molecular Biology, Surgical Inves- 
tigators, and Realistic Goals. Moderator: G. Patrick 
Clagett, MD. Panelists: John B. Sharetkin, MD, 
James C. Stanley, MD, Allan D. Callow, MD, PhD, 
Bauer E. Sumpio, MD, Louis K. Birinyi, MD, 
Alexander W. Clowes, MD. 
SESSION II. Gene Expression in Endothelial and 
Smooth Muscle Cells. Moderator: Linda M. Gra- 
ham, MD 
Regulation of Smooth Muscle Cell Function by 
Heparin. Alexander W. Clowes, MD 
Analysis of Local Gene Expression i  Human Athero- 
sclerotic Plaques. Josiah N. Wilcox, MD 
Inducible Gene Expression i  Vascular Wall Cells and 
Lcsional Leukocytes. Peter Libby, MD 
Vascular Smooth Muscle Cell Extracellular Matrix. 
David J. Carey, PhD 
Flow-Mediated Modulation of Selected Biologic and 
Molecular Determinants Related to Vascular En- 
dothelial Activation. Eugene S. Sprague, PhD 
Drug Effects on Vascular Wall Cell Gene Expression: 
A Probe of the Molecular Biology of the Early 
Hyperplasia/Late Fibrosis Response to Large Ves- 
sel Injury. John B. Sharefl~in, MD 
Analysis of the ELAM- 1 and VCAM- 1 Promoters-- 
Tools to Target Gene Expression to Endothe- 
lium in Transgenic Animals. Tucker Collin, 
MD, PhD 
Panel Discussion. Alexander W. Clowes, MD, Josiah 
N. Wilcox, MD, Peter Libby, MD, David J. Carey, 
PhD, Eugene A. Sprague, PhD, John B. Sharefldn, 
MD, Tucker Collins, MD, PhD 
NIH Grant Application Process and Guidelines: Ses- 
sion for New Grant Applicants. James S. T. Yao, 
MD, PhD, Paul Parakkal, PhD 
SESSION III. Genetic Vascular Disease. Moderator: 
M. David Tilson, MD 
Rational for Molecular Approaches to the Etiology of 
Abdominal Aortic Aneurysm Disease. M. David 
Tilson, MD 
Abnormalities inCollagen Biosynthesis and Abdomi- 
nal Aortic Aneurysm Disease. Susan Deak, MD 
Molecular Biology of the Marfan Syndrome. Harry C. 
Dietz, MD 
DNA Sequencing as a Method to Identify Muta- 
tions in Patients with Familial Forms of Aneu- 
rysms. Gerard Tromp, MD, Helena Kuivanieme, 
MD 
Genetic Defects of Lipoprotein Metabolism. Helen 
H. Hobbs, MD 
Mapping Genes for Hypertension. Victor J. Dzau, 
MD 
Panel Discussion. M. David Tilson, MD, Susan 
Deak, MD, Harry C. Dietz, MD, Helen H. 
Hobbs, MD, Victor J. Dzau, MD 
SESSION IV. Gene Therapy and Genetic Engineer- 
ing. Moderator: James C. Stanley, MD 
Direct Gene Transfer into the Arterial Wall. Eliza- 
beth G. Nabel, MD 
Repopulation of Injured Arteries with Genetically 
Modified Endothelial Cells. Louis K. Birinyi, MD 
Antisense Technology to Block Autocrine Growth 
Factor. Victor J. Dzau, MD 
Gene Transfer in the Treatment of Thrombosis and 
Other Focal Vascular Diseases. David A. Dichek, 
MD, NIH 
Gene Therapy and Molecular Pharmacology. Allan 
D. Callow, MD, PhD 
Panel Discussion. Elizabeth G. Nabel, MD, Louis K. 
Birinyi, MD, Victor H. Dzau, MD, David A. 
Dichek, MD, Allan D. Callow, MD, PhD 
1993 
SESSION I. Introductory Remarks and Update on 
NHLBI Programs. G. Patrick Clagett, MD 
Program Projects in Vascular Medicine and Aca- 
demic Awards. David M. Robinson, PhD, NHLBI 
SCOR's in Cardiovascular Disease. Constance Wein- 
stein, PhD, NHLBI 
Programs of Excellence in Molecular Biology. 
Stephen C. Mockrin, PhD. NIH 
SESSION II. Ischemia/Reperfusion: I troduction 
and Fundamental Concepts. Moderator: Malcolm 
O. Perry, MD 
Ischemia/Reperfusion Syndromes--Clinical Rel- 
evance. Malcolm O. Perry, MD 
Mechanisms of Reperfusion-Induced Microvascular 
Dysfunction. D. Nell Granger, PhD 
Complement, Neutrophils, Free Radicals in Myo- 
cardial Reperfusion I jury. Benedict R. Lucchesi, 
PhD, MD 
Leukocyte In Vivo Behavior. Karl E. Arfors, PhD 
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Adhesion Molecules and Ischemia-Reperfusion In- 
jury--Molecular nd Cellular Evidence for a Bor- 
der Zone: Mark L. Entmann, MD 
Ischemia, Relflerfusion and Organ Dysfunction. Peter 
A. Ward, MD 
Panel Discussion. Malcolm O. Perry, MD, D. Nell 
Granger, MD, Benedict R. Lucchesi, PhD, MD, 
Karl I. Arfors, PhD, Mark L. Entman, MD, Peter A. 
Ward, MD 
SESSION III. Skeletal Muscle Gastrointestinal 
Ischemia/Reperfusion. Moderator: Robert W. 
Hobson, II, MD 
Skeletal Muscle Ischemia/Reperfusion Interventions 
Based on Mechanisms of Injury. Paul M. Walker, 
MD 
Microcirculatory Dysfunction in Ischemia-Reperfu- 
sion Injury. Walter Duran, PhD 
Microvascular Dysfunction i  Postischemic Skeletal 
Muscle. Ronald J. Korthuis, PhD 
Regulation of Splanchnic Blood Flow Following 
Hemorrhage/Reperfusion. Smart I. Myers, MD 
Endothelial Xanthine Oxidase, A Fundamental In- 
flammatory Signal Transduction System: Physi- 
ologic and Pathophysiologic Implications. Gre- 
gory B. Bulkley, MD 
Panel Discussion. Robert A. Hobson, II, MD, Paul 
M. Walker, MD, Walter Duran, PhD, Ronald J. 
Dorthuis, PhD, Smart I. Myers, MD, Gregory B. 
Bulkley, MD 
SESSION IV. Cardiopulmonary and CNS 
Ischemia/Reperfusion. Moderator: Gerald B. Ze- 
lenock, MD 
Cardiovascular Reperfusion Injury. Lawrence D. 
Horwitz, MD 
Endothelial Adhesion Molecules and Myocardial Is- 
chemia-Reperfusion Injury. Allan M. Lefer, PhD 
Induction of Endogenous Myocardial Defenses 
Against Scheduled Ischemia Reperfusion. Ani Ban- 
erjee, PhD 
Perivascular Monocyte/Macrophage Interaction 
With Endothelium as a Mechanism Through 
Which Stroke-Risk Factors Operate to Increase 
Stroke Likelihood. John M. Hallenbeck, MD 
Therapy of Experimental Spinal Cord Ischemia. Jus- 
tin A. Zivin, MD, PhD 
Rheologic Mechanisms in Brain Ischemia: Regula- 
tory Aspects. Bruce M. Coull, MD 
Panel Discussion. Gerald B. Zelenick, MD, Lawrence 
D. Horwitz, MD, Allan M. Lefer, PhD, Ani Ban- 
erjee, PhD, John M. Hallenbeck, MD, Justin A. 
Zivin, MD, PhD, Bruce Coull, MD 
SESSION V. Shock and MSOF. Moderator: Jureta A. 
Horton, PhD 
The Contribution of Oxygen Free Radicals and Lipid 
Peroxidation to Cardiac Dysfunction After Burn 
Injury. Jureta A. Horton, PhD 
Programmed Cell Death in Endothelial Cells Follow- 
ing Sequential Endotoxin and Heat Stresses. Timo- 
thy G. Buchman, MD, PhD 
Local and Remote Injury Following Gut Ischemia. 
Herbert B. Hechtman, MD 
The Systemic Consequences of Intestinal 
Ischemia/Reperfusion Injury. Keith T. Oldham, 
MD 
Panel Discussion. Jureta A. Horton, PhD, Timothy 
G. Buchman, MD, PhD, Herbert B. Hechtman, 
MD, Keith T. Oldham, MD 
1994 
SESSION I. Introductory Remarks and Update on 
NHLBI Programs. G. Patrick Clagett, MD, Mod- 
erator 
Programs in Vascular Disease: Activities of the De- 
vices and Technology Branch, NHLBI. Paul Did- 
isheim, MD, NHLBI 
Vascular Biology, Medicine, and Surgery Programs at 
the NHLBI. David M. Robinson, PhD, NIH 
Division of Heart and Vascular Diseases: New Initia- 
tives and Furore Funding. Michael Horan, MD, 
ScM, NIH 
SESSION II. Atherosclerosis. Moderator: Christo- 
pher K. Zarins, MD 
Advantages and Shortcomings of Animal Models in 
Atherosclerosis Research. Robert W. Wissler, PhD, 
MD 
Hemodynamic Manipulation and Animal Models of 
Atherogenesis. Christopher K. Zarins, MD 
In Vivo to In Vitro to In Vivo: Utilization of New In 
Sire Techniques for the Study of Atherosclerosis. 
Michael E. Rosenfeld, PhD 
What Can Be Learned from In Vitro Hemodynamic 
Flow Models. Don P. Giddens, PhD 
What Is the Relevance of Experimental Models of 
Lipid Plaque Formation or Artery Wall Injury to 
the Clinical Evaluation fHuman Atherosclerotic 
Lesions? Seymour Glagov, MD 
Panel Discussion. Robert W. Wissler, PhD, MD, 
Christopher K. Zarins, MD, Michael E. Rosenfeld, 
PhD, Don G. Giddens, PhD, Seymour Glagov, MD 
SESSION III. Thrombosis/Antithrombotic Ther- 
apy. Moderator: G. Patrick Clagett, MD 
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The Role of Thrombin in Vascular Lesion Formation 
in Nonhuman Primates. Laurence A. Harker, MD 
The Human Placental Artery: A Model for the Study 
of the Cornerstone ofThrombogenesis. Peter C. 
Johnson, MD 
Surface Conditioning by Plasma Proteins: Help or 
Hindrance. Robert C. Eberhart, PhD 
Alternatives to Animal Models. Michael Sobel, MD 
Thrombosis on Atherosclerotic Lesions: Implications 
for Therapy. Lina Badimon, PhD 
Panel Discussion. G. Patrick Clagett, MD, Laurence 
A. Harker, MD, Peter C. Johnson, MD, Robert C. 
Eberhart, PhD, Michael Sobel, MD, Lina Badi- 
mon, PhD 
SESSION IV. Vascular Prostheses/Healing. 
Moderator: Frank W. LoGerfo, MD 
Research Models in Cardiovascular Device Evalua- 
tion. Howard P. Greisler, MD 
Type V Collagen and High Molecular Weight I(finino- 
gen Inhibition of Endothelial Cell Adhesion and 
Growth. Nicholas P. Ziats, MD 
Platelet Interaction with Vascular Protheses: Does It 
Cause Intimal Hyperplasia? G.Patrick Clagett, MD 
Molecular Mechanisms of Microbial Adhesion to 
Host Proteins. Magnus Hook, PhD 
SESSION V. Intima ! Hyperplasia. Moderator: Harry 
L. Bush, Jr., MD 
Research Models ofInitimal Hyperplasia: Advantages 
and Shortcomings of Studies in the Nonhuman Pri- 
mate. Harry L. Bush, Jr., MD 
The Building and Characterization f"Designer Inti- 
mas." Alexander W. Clowes, MD 
Modeling Vein Graft Pathophysiology. Per-Otto 
Hagen, PhD 
Panel Discussion. Harry L. Bush, Jr., MD, Alexander 
W. Clowes, MD, Per-Otto Hagen, PhD, Frank W. 
LoGerfo, MD, Howard R Greisler, MD, Nicholas 
P. Ziats, PhD, Patrick Clagett, MD, Magnus Hook, 
PhD 
Minisymposium: NIH Funding Opportunities for 
Vascular Surgeons. Moderator: G. Patrick Clagett, 
MD 
The Importance ofResearch Training: Opportunities 
Available through the NHLBI. John L. Fakunding, 
PhD, NHLBI 
The Harvard-Longwood Training Program in 
Vascular Surgery Research. Frank W. LoGerfo, 
MD 
How, Why, and What Grants Get Funded. Paul Par- 
akkal, PhD 
SESSION VI. In Vitro Methods and Computer 
Modeling. Moderator: K. Wayne Johnston, 
MD 
Development of In Vitro Pulsatile Pressure and 
Cyclic Strain Models. Bauer E. Sumpio, MD, 
PhD 
Flow Patterns and Preferred Sites of Vascular Diseases 
Observed in Transparent Natural Blood Vessels. 
Takeshi Karino, PhD 
Hemodynamic Assessments with the Photochromic 
Tracer Technique. Matadial Ojha, PhD 
The Use of Computer Flow Modelling in Hemody- 
namic Studies. C. Ross Ethier, PhD 
Panel Discussion. K. Wayne Johnston, MD, Bauer E. 
Sumpio, MD, PhD, Takeshi Karino, PhD, Matadial 
Ojha, PhD, C. Ross Ethier, PhD 
SESSION VII. Aneurysms. Moderator: M. David Til- 
son, MD 
Aortic Aneurysms of the Blotchy Mouse. M. David 
Tilson, MD 
Aneurysms of the Allografted Aorta in Inbred Rats. 
William M. Abbott, MD 
In Vivo Model of Aortic Aneurysm. Philip B. Dobrin, 
MD, PhD 
Drug Modulation of Aortic Elastin and Collagen in 
the Aneurysm-Prone Turkey. Zeenat Gunja-Smith, 
PhD 
In Vivo Aneurysm Formation in the Rabbit after 
Tropical Adventitial Elastolysis. John V. White, 
MD 
Aortic Disease in Transgenic Mice Containing Elastin 
Gene Mutations. Charles Boyd, PhD 
Panel Discussion. M. David Tilson, MD, William M. 
Abbott, MD, Philip B. Dobrin, MD, PhD, Zeenat 
Gunja-Smith, PhD, John V. White, MD, Charles 
Boyd, PhD 
Symposium on Transluminally Placed Endovascular 
Prostheses. Moderator: William M. Abbott, PhD 
Introduction and Overview. William M. Abbott, MD 
SESSION I. Devices 1994: What Do We Know, What 
Do We Need To Know? 
Design Considerations: The Basic Idea and What 
Needs to Be Achieved. Jerry Goldstone, MD 
Delivery Systems: What Exists, What Are the Prob- 
lems, and Can They Be Solved? John E. Abele 
Attachment Devices: What's Available, What's Im- 
portant, and Do They Need Improvement? Julio 
Palmaz, MD 
Prostheses: What Are Important Properties, What 
Are Acceptable Compromises? William M. Abbott, 
MD 
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SESSION II. Evaluation of Device Systems. 
Effect of Aortic and Iliac Arterial Anatomy on the 
Feasibility of Endovascular Aneurysm Repair: 
Straight Versus Bifurcated Grafts. Timothy A. M. 
Churter, MD 
In Vitro and In Vivo Models of Aneurysms and Test 
Devices. Carlos E. Donayre, MD 
Important Healing and Other Physiologic Param- 
eters. Richard M. Green, MD 
SESSION III. Evaluation of Patient for Potential De- 
vice Placement. 
Important Vascular Morphologic Parameters. Will- 
iam H. Pearce, MD 
Imaging Systems--MRI, Anglo, and CT: Which is 
the Best? Michael Dalce, MD 
Intravascular Ultrasound and the Role in Patient Se- 
lection and Device Placement. Rodney A. White, 
MD 
SESSION IV. Current Status--Clinical Results: Suc- 
cess and Problems. 
Abdominal Aortic Aneurysms. Juan C. Parodi, MD 
Endovascular Stented Grafts in the Treatment of Aor- 
toiliac and Femoropopliteal Occlusive Disease. 
Frank J. Veith, MD 
Repair of Non-Aortic Aneurysms and Penetrating 
Traumatic Arterial Injuries. Michael L. Marin, MD 
Thoracic Aortic Problems and Dissections. D. Craig 
Miller, MD 
Panel Discussion. Juan C. Parodi, MD, Frank J. Veith, 
MD, Michael L. Marin, MD, D. Craig Miller, MD 
SESSION V. The Appropriate Patient for This Tech- 
nology in 1994. 
Selection of Patients for Endovascular Graft Repair of 
Abdominal Aortic Aneurysms: The UCLA Experi- 
ence. Wesley S. Moore, MD 
SESSION VI. Implementing New High 
Technology: How and Who? 
An FDA Scientist's View. Dorothy B. Abel 
A Clinician's View. James S. T. Yao, MD, PhD 
Risk 
SESSION VII. Future Considerations and What's 
Ahead. 
Future Considerations in Percutaneous Endovascular 
Graft Placement: A Vascular Radiologist's View. 
Andrew H. Cragg, MD 
A Vascular Surgeon's View. Thomas J. Fogarty, MD 
1995 
Introduction. Alexander W. Clowes, MD 
Opportunities for Research in Vascular Disease at 
NHLBI. David M. Robinson, MD 
Research Training Opportunities for Vascular Sur- 
geons at NHLBI. Joyce A. Hunter, PhD 
SESSION I. The Problem: Why Don't Animal Ex- 
periments Predict Outcomes in Humans? 
Moderator: Alexander W. Clowes, MD 
Why Animal Experiments Do Not Predict Outcomes 
in Humans. Stephen M. Schwartz, MD, PhD 
Adaptation to Atherosclerosis: Human vs Animal. 
Christopher K. Zarins, MD 
Reactivity of Athcrosclerotic Vessels in Monkey and 
Humans. Donald D. Heistad, MD 
SESSION II. Animal Models: Their Limitations. 
Moderator: Alexander W. Clowes, MD 
Cellular Processes Involved in the Growth of Vascular 
Intimal Lesions. Michael A. Reidy, PhD 
The Limitations of the Pig Athero/Injury Model. 
Robert S. Schwartz, MD 
The Limitations of the Rabbit Athero/Injury Model. 
Ian J. Sarembock, MB, ChB, MD 
Panel Discussion. Stephen M. Schwartz, MD, PhD, 
Christopher K. Zarins, MD, Donald D. Heistad, 
MD, Michael A. Reidy, PhD, Robert S. Schwartz, 
MD, Ian J. Sarembock, MB, ChB, MD 
SESSION III. Techniques for Studying Vascular Dis- 
ease in Humans. Moderator: James S. T. Yao, MD, 
PhD 
MR Microscopy in Vascular Models. G. Allan 
Johnson, PhD 
The Use of Carotid Artery Diameter Waveforms to 
Identify Peripheral Artery Occlusions. Ralph W. 
Barnes, PhD 
The Current Use and Future of Intraluminal Ultra- 
sound. Peter Fitzgerald, MD 
The Current Use and Future of Transesophageal Ul-
trasound. William H. Pearce, MD 
SESSION IV. Why Do Some Lesions Cause Throm- 
boembolic Symptoms? Moderator: G. Patrick 
Clagett, MD 
Thrombosis on Human Plaques. Erling Falk, MD, 
PhD 
Inflammation and Disruption in Human Plaques. Pe- 
ter Libby, MD 
Mechanisms of Embolization. James T. Willerson, 
MD 
Tissue Characterization f the Plaque and Thrombus: 
Pathogenetic and Clinical Implications. Valentin 
Fuster, MD, PhD 
Panel Discussion. G. Allan Johnson, PhD, Ralph W. 
Barnes, PhD, Peter Fitzgerald, MD, William 
Pearce, MD, Erling Falk, MD, PhD, Peter Libby, 
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MD, James T. Willerson, MD, Valentin Fuster, 
MD, PhD 
SESSION V. Plaque Progression and Abnormalities 
of Vasomotor Function. Moderator: D. Eugene 
Strandness, Jr., MD 
Potential of MR Imaging and Spectroscopy for 
Plaque Characterization. Gerald M. Pohost, MD 
Ultrasonic Characterization of Atherosclerotic 
Plaque. K. Kirk Shung, PhD 
Vasomotor Function in Humans with Atherosclerosis 
and Risk Factors for Atherosclerosis. Mark A. Crea- 
ger, MD 
Progression and Regression: Role of NO. John P. 
Cooke, MD, PhD 
Risk Factors for Early Intima-Media Thickening in 
Carotid Arteries. A. Richey Sharrett, MD, PhD 
Progression of Carotid Atherosclerosis. Daniel H. 
O'Leary, MD 
SESSION VI. Mechanisms of Restenosis After Vascu- 
lar Reconstruction. Moderator: FrankW. LoGerfo, 
MD 
Mechanisms of Restenosis after Coronary Angio- 
plasty. David P. Faxon, MD 
Disease Progression and Restenosis after Carotid En- 
darterectomy. D. Eugene Strandness, Jr., MD 
Mechanisms of Restenosis after Lower Extremity An- 
gioplasty. Jeffrey M. Isner, MD 
Stenosis in Vein Grafts. Dennis F. Bandyk, MD 
Panel Discussion. Gerald M. Pohost, MD, K. Kirk 
Shund, PhD, Mark A. Creager, MD, John P. Cook, 
MD, PhD, A. Richey Sharrett, MD, PhD, Daniel 
H. O'Leary, MD, David P. Faxon, MD, D. Eugene 
Strandness, Jr., MD, Jeffrey M. Isner, MD, Dennis 
F. Bandyk, MD 
1996 
SESSION I. 
Introductory Remarks. Alexander W. Clowes, MD 
The Potential and Challenges of Gene Therapy. 
Stephen Mockrin, PhD, Sonia Skarlatos, PhD 
Overview on Genc Transfer. Recombinant Gene 
Transfer: Scientific Insights, Disease Pathogenesis, 
and Potential to Treat Human Disease. Gary Na- 
bel, MD, PhD 
SESSION II. Animal Models of Disease. Moderator: 
Alexander W. Clowes, MD 
Lipid Disorders, Lp(a) and Atherosclerosis in Trans- 
genic Mice. Russell Ross, PhD 
Transplant Atherosclerosis in Mice. Peter Libby, MD 
Murine Models of Fibrinolytic Disorders. Peter Car- 
meliet, MD, PhD 
Arterial Response to Injury in the Mouse. Michael A. 
Reidy, PhD 
Studies in Transgenic Rabbits. John Taylor, PhD 
Panel Discussion. Gary Nabel, MD, PhD, Rus- 
sell Ross, PhD, Peter Libby MD, Peter Carmeliet, 
MD, PhD, Michael A. Reidy, PhD, John Taylor, 
PhD 
SESSION III. Therapy Based on Gene Transfer. 
Moderator: James C. Stanley, MD 
A: Methods for Local Gene Delivery. 
Methods for Local Gene Delivery. Keith March, MD 
B: Cell-Based Transfer, 
Endothelial Cells for Systemic and Local Gene 
Therapy. Louis Messina, MD 
Cell-Based Gene Transfer in Biomaterials. Allan Cal- 
low, MD, PhD 
Smooth Muscle Cells for Systemic and Local Therapy. 
Alexander W. Clowes, MD 
INOS Overexpression to Modify Disease States. 
Timothy R. Billiar, MD 
C: Direct Transfer--Viral Approaches 
Adenoviral Vectors: Promises and Pitfalls. Mark Kay, 
MD, PhD 
Modification of Vein Graft Function Using Adenovi- 
ral Vectors. Michael Golden, MD 
Adenoviral Approaches for Controlling Intimal Hy- 
perplasia. Jeffrey M. I~iden, MD, PhD 
Local Pharmacological Approaches to Regualation of 
Fibrinolysis. David Dichek, MD 
Panel Discussion. Keith March, MD, Louis Messina, 
MD, Allan Callow, MD, PhD, Alexander W. 
Clowes, MD, Mark Kay, MD, PhD, Michael 
Golden, MD, Jeffrey M. Leiden, MD, PhD, David 
Dichek, MD 
D: Direct Transfer Nonviral Approaches. 
Moderator: Howard Greisler, MD 
ecNOS and Intimal Hyperplasia. Gary H. Gibbons, 
MD 
Antisense Strategies for Controlling the Vascular Re- 
sponse to Injury. Elazer Edelman, MD 
Antisense C-MYC Therapy. Blair A. Keagy, MD 
E: Genetically Enhanced Cardiovascular Implants. 
Moderator: Paul Didisheim, MD 
Polymers for Local Release of Bioactive Substances. 
Neal L. Eigler, MD 
Modification of Artificial Heart by Gene Transfer. 
Timothy Scott-Burden, PhD 
Genetic Modification oflntravascular Stents. Robert 
Eberhart, PhD 
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SESSION IV. Clincial Trials Involving Vascular Gene 
Transfer. Moderator: Elizabeth G. Nabel, MD 
VEGF Overexpression a d Angiogenesis. Jeffrey M. 
Isner, MD 
Cytostatic Therapy for Vascular Proliferative Disor- 
ders. Elizabeth G. Nabel, MD 
Panel Discussion. Gary H. Gibbon, MD, Elazer Edel- 
mann, MD, Blair A. Keagy, MD, Neal L. Eigler, 
MD, Timothy Scott-Burden, PhD, Robert Eber- 
hart, PhD, Jeffrey M. Isner, MD, Elizabeth G. Na- 
bel, MD 
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